Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries

被引:15
|
作者
Giannopoulos, Stefanos [1 ]
Strobel, Aaron [1 ]
Rudofker, Eric [1 ]
Kovach, Christopher [1 ]
Schneider, Peter A. [2 ]
Armstrong, Ehrin J. [1 ]
机构
[1] Univ Colorado, Rocky Mt Reg VA Med Ctr, Div Cardiol, Denver, CO 80202 USA
[2] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94143 USA
关键词
dissection; endovascular therapy; drug-coated balloon; paclitaxel coated balloon; peripheral artery disease; LOWER-EXTREMITY; ENDOVASCULAR INTERVENTIONS; TASK-FORCE; DISEASE; MANAGEMENT; CALCIFICATION; CONSENSUS; PATTERNS; SURGERY; IMPACT;
D O I
10.1177/15266028211016441
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Balloon angioplasty for the treatment of femoropopliteal lesions is often complicated by postangioplasty dissections. While dissections are known to affect patency and reintervention after balloon angioplasty, the association between dissections and major adverse limb event (MALE) after drug-coated balloon (DCB) angioplasty remains uncertain. Thus, the postangioplasty dissection and bailout stenting patterns were investigated. Materials and Methods: This was a single-center retrospective study enrolling patients with de novo femoropopliteal lesions treated with DCB with/without stenting. Postangioplasty target vessel dissection was graded based to the coronary artery classification grades A-F, with grade C-F considered "severe." Cox regression analysis was performed to examine the association of dissection severity with outcomes during 2-year follow up, among nonstented cases. Results: In 85.3% of the cases (N=203/238) a postangioplasty dissection was observed. The average dissection length was 55.57 mm (SD 36.71 mm), with 1 dissection present in 91.8% (N=180/196) and 2 or more dissections present in 8.2% (N=16/196). Dissection severity was grade A (19.8%), B (20.6%), C (23.1%), D (10.9%), E (10.1%), and F (0.8%). Bailout stenting was required in 40.4% of the patients, being more prevalent among grade C and grade E cases. Among 142 nonstented cases, dissections were present in 85.2%. A total of 75 (52.8%) of these dissections were grade A and B, while 46 (32.4%) were grade C to F. Among nonstented cases, grade C (hazard ratio [HR] 5.83; 95% CI 1.25 to 27.31; p=0.025) and grade D (HR 6.32; 95% CI 1.39 to 28.86; p=0.017) vs grade A dissections were associated with a higher risk for 2-year MALE. Multivariate analysis adjusting for several lesion characteristics demonstrated a statistically significant higher risk for 2-year MALE among the severe dissection group (HR 2.94; 95% CI 1.27 to 6.79; p = 0.012). Interestingly, the risks of limb loss (HR 1.30; 95% CI 0.22 to 7.79; p=0.774) and repeat revascularization (HR 0.95; 95% CI 0.40 to 2.26; p=0.905) during follow-up were similar between the 2 groups. Conclusion: This study indicated that nonstented moderate and severe postangioplasty dissections after DCB angioplasty were associated with higher risk for MALE. Future studies are needed to validate our results and determine other dissection characteristics (eg, total dissection length, lumen area, total number of dissections) that may affect the efficacy of DCB.
引用
收藏
页码:593 / 603
页数:11
相关论文
共 50 条
  • [31] Drug-Coated Balloon Angioplasty Confers No Advantage in the Treatment of Femoropopliteal Disease When Stenting Is Required
    Tiu, Brian
    Shih, Michael
    Shiferson, Alexander
    Hua, Qing
    Jacob, Theresa
    Rhee, Robert
    JOURNAL OF VASCULAR SURGERY, 2018, 68 (02) : E22 - E23
  • [32] Intraluminal vs Subintimal Drug-Coated Balloon Angioplasty for the Treatment of Femoropopliteal Chronic Total Occlusions
    Toyoshima, Taku
    Takahara, Mitsuyoshi
    Iida, Osamu
    Tomoi, Yusuke
    Kawasaki, Daizo
    Tanaka, Akiko
    Yamauchi, Yasutaka
    Tobita, Kazuki
    Kozuki, Amane
    Fujihara, Masahiko
    Higuchi, Yoshiharu
    Soga, Yoshimitsu
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (05) : 608 - 618
  • [33] Leaving Nothing Is Leaving Unanswered Questions -Drug-Coated Balloon Angioplasty for Femoropopliteal Artery-
    Shibahashi, Eiji
    Jujo, Kentaro
    CIRCULATION JOURNAL, 2021, 85 (12) : 2157 - 2158
  • [34] Evaluation of Mortality Following Paclitaxel Drug-Coated Balloon Angioplasty of Femoropopliteal Lesions in the Real World
    Boehme, Tanja
    Noory, Elias
    Beschorner, Ulrich
    Jacques, Borries
    Buergelin, Karlheinz
    Macharzina, Roland
    Gebauer, Ellen
    Cheung, Florian
    Lechner, Peter
    Nuehrenberg, Thomas
    Zeller, Thomas
    JACC-CARDIOVASCULAR INTERVENTIONS, 2020, 13 (17) : 2052 - 2061
  • [35] Is Drug-Coated Balloon the Real Winner for Femoropopliteal Artery Intervention?
    Liistro, Francesco
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (13) : 1651 - 1653
  • [36] Diabetes mellitus and femoropopliteal in-stent restenosis: Insights from the dRug-coatEd balloon angioPlasty for femoropopliteAl In-stent Restenosis cooperation
    Voll, Felix
    Wolf, Florian
    Ingwersen, Maja
    Kinstner, Christian M.
    Kufner, Sebastian
    Ibrahim, Tareq
    Ott, Ilka
    Krankenberg, Hans
    Fusaro, Massimiliano
    Cassese, Salvatore
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2022, 51 (04) : 247 - 255
  • [37] Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes
    Rodoplu, Orhan
    Oztas, Didem Melis
    Meric, Mert
    Beyaz, Metin Onur
    Ulukan, Mustafa Ozer
    Yildiz, Cenk Eray
    Unal, Orcun
    Ugurlucan, Murat
    ANNALS OF VASCULAR SURGERY, 2021, 73 : 222 - 233
  • [38] Gender Differences in the Outcomes of Drug-Coated Balloon Treatment in Symptomatic Femoropopliteal Arterial Disease
    Krishnan, Prakash
    Tarricone, Arthur
    Purushottam, Bhaskar
    Chen, Simon
    Kapur, Vishal
    Gujja, Karthik
    Kini, Annapoorna
    Sharma, Samin
    VASCULAR AND ENDOVASCULAR SURGERY, 2020, 54 (04) : 348 - 354
  • [39] Two-year Review on Mortality and Morbidity after Femoropopliteal Drug-coated Balloon Angioplasty in the Randomized EffPac Trial
    Teichgraber, Ulf
    Lehmann, Thomas
    Aschenbach, Rene
    Thieme, Markus
    Zeller, Thomas
    Beschorner, Ulrich
    Scheinert, Dierk
    RADIOLOGY, 2020, 296 (03) : 638 - 640
  • [40] Impact of post-procedural peripheral fractional flow reserve after drug-coated balloon angioplasty in femoropopliteal lesions
    Iwasaki, Yoshihiro
    Shimada, Takenobu
    Koike, Jumpei
    Funatsu, Atsushi
    Kobayashi, Tomoko
    Ikeda, Takanori
    Nakamura, Shigeru
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 66 : 51 - 55